Y Intercept Hong Kong Ltd Decreases Holdings in National Health Investors, Inc. $NHI

Y Intercept Hong Kong Ltd lowered its position in National Health Investors, Inc. (NYSE:NHI) by 75.5% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,510 shares of the real estate investment trust’s stock after selling 23,202 shares during the period. Y Intercept Hong Kong Ltd’s holdings in National Health Investors were worth $607,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of NHI. NewEdge Advisors LLC raised its holdings in National Health Investors by 28.7% during the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock worth $114,000 after purchasing an additional 345 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of National Health Investors by 9.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock valued at $18,460,000 after buying an additional 21,851 shares in the last quarter. Jane Street Group LLC increased its position in shares of National Health Investors by 1,728.4% in the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock valued at $5,148,000 after buying an additional 65,885 shares in the last quarter. Cetera Investment Advisers raised its stake in shares of National Health Investors by 6.1% during the 2nd quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust’s stock worth $336,000 after buying an additional 275 shares during the last quarter. Finally, American Century Companies Inc. raised its stake in shares of National Health Investors by 2.2% during the 2nd quarter. American Century Companies Inc. now owns 19,236 shares of the real estate investment trust’s stock worth $1,349,000 after buying an additional 420 shares during the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO D. Eric Mendelsohn bought 1,500 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The shares were purchased at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the transaction, the chief executive officer owned 133,316 shares in the company, valued at $9,177,473.44. The trade was a 1.14% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Robert A. Mccabe, Jr. bought 890 shares of the stock in a transaction on Monday, June 15th. The stock was purchased at an average cost of $71.65 per share, with a total value of $63,768.50. Following the completion of the purchase, the director directly owned 44,159 shares in the company, valued at $3,163,992.35. This trade represents a 2.06% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 2.70% of the company’s stock.

National Health Investors Stock Up 0.8%

NHI opened at $75.92 on Tuesday. The firm has a market cap of $3.68 billion, a P/E ratio of 24.49, a PEG ratio of 3.38 and a beta of 0.51. The business’s fifty day simple moving average is $74.19 and its 200 day simple moving average is $79.59. National Health Investors, Inc. has a 52 week low of $67.94 and a 52 week high of $91.38. The company has a quick ratio of 8.20, a current ratio of 8.20 and a debt-to-equity ratio of 0.83.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Tuesday, June 30th will be given a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date of this dividend is Tuesday, June 30th. National Health Investors’s payout ratio is currently 118.71%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on NHI. Zacks Research cut shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. BMO Capital Markets reduced their price target on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a report on Monday, June 15th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $94.00 price target on shares of National Health Investors in a research report on Wednesday, April 22nd. Wells Fargo & Company dropped their price objective on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research note on Monday, June 1st. Finally, Weiss Ratings downgraded National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Five equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $83.86.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.